Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1170690

registered interest
date	14/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tranquillisers: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure specialist withdrawal services are available to support patients dependent on prescribed benzodiazepine and z drug tranquillisers.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	3212
answer	answer is ministerial correction date of answer 20/01/2020 answer text <p>In September 2019 Public Health England published an evidence review of medicines associated with dependence or withdrawal, including benzodiazepines and z drugs. The report is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/prescribed-medicines-review-report" target="_blank">https://www.gov.uk/government/publications/prescribed-medicines-review-report</a></p><p>Alongside ongoing improvements to medicines safety and the use of prescribed drugs, NHS England is reviewing the recommendations from this review and other evidence to develop a set of actions to reduce and treat prescription medicine dependency.</p><p>A national review of overprescribing in the National Health Service is being led by Chief Pharmaceutical Officer Dr Keith Ridge and will be published in 2020. This will focus on people who take multiple medicines to ensure patients are receiving the most appropriate treatment for their needs. The review will consider how to improve management of non-reviewed repeat prescriptions including prescriptions beyond guidelines, and the role of digital technologies in reducing overprescribing.</p><p>The Government is committed to growing the workforce by 6,000 more doctors in general practice and 6,000 more primary care professionals, including pharmacists. This is on top of the additional 20,000 primary care professionals NHS England are providing funding towards recruiting. Community pharmacists have a key role in monitoring the care and treatment of patients, and would be in a position to review a patient’s medication usage and prescriptions.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 3214 3215 question first answered 20/01/2020 15:33:23 answering member 4380 label Biography information for Jo Churchill
tabling member	4212 label Biography information for Debbie Abrahams

1170694

registered interest
date	14/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the 2020 cross-government addiction strategy will include proposals on treatment for people who have become dependent on drugs prescribed by their doctor.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	3215
answer	answer is ministerial correction date of answer 20/01/2020 answer text <p>In September 2019 Public Health England published an evidence review of medicines associated with dependence or withdrawal, including benzodiazepines and z drugs. The report is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/prescribed-medicines-review-report" target="_blank">https://www.gov.uk/government/publications/prescribed-medicines-review-report</a></p><p>Alongside ongoing improvements to medicines safety and the use of prescribed drugs, NHS England is reviewing the recommendations from this review and other evidence to develop a set of actions to reduce and treat prescription medicine dependency.</p><p>A national review of overprescribing in the National Health Service is being led by Chief Pharmaceutical Officer Dr Keith Ridge and will be published in 2020. This will focus on people who take multiple medicines to ensure patients are receiving the most appropriate treatment for their needs. The review will consider how to improve management of non-reviewed repeat prescriptions including prescriptions beyond guidelines, and the role of digital technologies in reducing overprescribing.</p><p>The Government is committed to growing the workforce by 6,000 more doctors in general practice and 6,000 more primary care professionals, including pharmacists. This is on top of the additional 20,000 primary care professionals NHS England are providing funding towards recruiting. Community pharmacists have a key role in monitoring the care and treatment of patients, and would be in a position to review a patient’s medication usage and prescriptions.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 3212 3214 question first answered 20/01/2020 15:33:23 answering member 4380 label Biography information for Jo Churchill
tabling member	4212 label Biography information for Debbie Abrahams

1144443

registered interest
date	03/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with Oldham Council on the potential effect of the UK leaving the EU without a withdrawal agreement on the availability of medicines.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	286245
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that our plans should ensure the supply of medicines and medical products when we leave the EU on 31 October.</p><p>The Department, alongside NHS England and NHS Improvement, are ensuring that there is regular communication with frontline National Health Service organisations and stakeholders in the health and social care sector regarding EU Exit preparations. NHS England and NHS Improvement will be holding EU Exit roadshows in the lead up to 31 October, building on the regular communication that the Department and NHS England and NHS Improvement has with the frontline.</p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 17:05:08 answering member 4021 label Biography information for Chris Skidmore
tabling member	4212 label Biography information for Debbie Abrahams

1143674

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the finding in the Royal College of Psychiatrists fourth annual National Audit of Dementia Care in General Hospitals 2018-19 that 40 per cent of patients with dementia are not being given an initial assessment for delirium, what steps his Department is taking to ensure that all patients with delirium are given an initial delirium assessment as set out in NICE guidelines.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	285278
answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) clinical guidelines provide recommendations for the care of individuals in specific clinical conditions or circumstances within the National Health Service. NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence. The guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p><p>One of the key priorities of NHS England’s Long Term Plan is to reduce avoidable admissions to hospital and to ensure that, when admission is needed, people with dementia and delirium experience the best possible care.</p><p>We are committed to further expanding the provision of liaison mental health services so that no acute hospital is without an all-age mental health liaison service in accident and emergency (A&amp;E) departments and inpatient wards by 2020/21. The establishment of acute frailty services in all hospitals with a major A&amp;E department by the end of 2019 will ensure that patients can be assessed, treated and supported by skilled multidisciplinary teams delivering a geriatric assessment within the first hour of arrival. These services will support better identification and treatment of dementia and delirium in hospitals.</p><p> </p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/09/2019 12:10:19 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4212 label Biography information for Debbie Abrahams

1143888

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Care Homes: Oldham
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with (a) Oldham Council and (b) Oldham Clinical Commissioning Group on the potential effect on staffing levels in care homes of the UK leaving the EU without a withdrawal agreement.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	285280
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>The Department is working closely with local government, other Government departments, and with national partners including the Local Government Association and Association of Directors of Adult Social Services, to do everything appropriate to prepare for a ‘no deal’ exit on 31 October 2019. This will ensure that the potential impacts of exiting the European Union on vulnerable people using adult social care services are mitigated as far as possible.</p><p>The Department continues to monitor and analyse overall staffing levels in the social care sector and we have been monitoring leaver and joiner rates of EU staff on a regular basis since the 2016 referendum. We are not complacent and have plans in place to ensure there will continue to be sufficient staff to deliver the high-quality services on which the public relies. Our overall programme of work is comprehensive, thorough and continuously updated and will stand irrespective of the terms in which the United Kingdom leaves the EU.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 09/09/2019 16:07:44 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4212 label Biography information for Debbie Abrahams

1143889

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pennine Acute Hospitals NHS Trust: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with Pennine Acute Hospitals NHS Trust on the potential effect on NHS staffing levels of the UK leaving the EU without a withdrawal agreement.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	285281
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>The Department, alongside NHS England and NHS Improvement, is ensuring that there is regular communication with frontline National Health Service organisations regarding European Union exit preparations.</p><p> </p><p>We have published EU exit operational readiness guidance for the health and care system in England outlining actions that providers and commissioners of health and social care services should take to prepare for, and manage, the risks of the United Kingdom leaving the EU. We do not currently expect the manner by which the UK leaves the EU to have a significant impact on NHS staffing levels on or around exit day.</p><p>We are, however, not complacent and have plans in place to ensure there will continue to be sufficient staff to deliver the high-quality services on which the public relies. Our overall programme of work is comprehensive, thorough and continuously updated and will stand irrespective of the terms in which the UK leaves the EU. We continue to monitor and analyse overall staffing levels in the NHS and social care sector and we have been monitoring leaver and joiner rates of EU staff on a regular basis since the 2016 referendum. In addition, individual organisations can escalate concerns through existing reporting mechanisms to ensure there is regional and national oversight.</p><p> </p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 18:50:20 answering member 4021 label Biography information for Chris Skidmore
tabling member	4212 label Biography information for Debbie Abrahams

1138637

registered interest
date	09/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Restraint Equipment: Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to prevent online retailers from selling products that are labelled dementia restraints to the public.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	276537
answer	answer is ministerial correction date of answer 17/07/2019 answer text <p>There is a robust legal framework relating to the use of restrictive practices, including the Human Rights Act 2008, Mental Health Act 1983, and the Mental Capacity Act 2005. Restrictive interventions should only be used in line with the legal framework, and by people with the appropriate training in the application of those practices, where there is a real possibility of harm to the person or to staff, the public or other. Mechanical restraints should never be a first line means of managing disturbed behaviour.</p><p>We will consider the most effective way to ensure all online retailers are made aware of the risks and ethical implications of selling products labelled in this way to the public.</p><p>The Government remains committed to delivering the Challenge on Dementia 2020 in full to make England the best place in the world for people with dementia to live.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 276538 question first answered 17/07/2019 15:20:20 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4212 label Biography information for Debbie Abrahams

1138638

registered interest
date	09/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Restraint Equipment: Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to raise awareness among online retailers of the risks and ethical implications of selling products that are labelled dementia restraints to the public.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	276538
answer	answer is ministerial correction date of answer 17/07/2019 answer text <p>There is a robust legal framework relating to the use of restrictive practices, including the Human Rights Act 2008, Mental Health Act 1983, and the Mental Capacity Act 2005. Restrictive interventions should only be used in line with the legal framework, and by people with the appropriate training in the application of those practices, where there is a real possibility of harm to the person or to staff, the public or other. Mechanical restraints should never be a first line means of managing disturbed behaviour.</p><p>We will consider the most effective way to ensure all online retailers are made aware of the risks and ethical implications of selling products labelled in this way to the public.</p><p>The Government remains committed to delivering the Challenge on Dementia 2020 in full to make England the best place in the world for people with dementia to live.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 276537 question first answered 17/07/2019 15:20:20 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4212 label Biography information for Debbie Abrahams

1063827

registered interest
date	18/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Nurses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of patients with secondary breast cancer have a dedicated nurse specialist allocated to them.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	222762
answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The NHS Cancer Programme aims to improve access to cancer Clinical Nurse Specialists (CNS) for all cancer patients when they need it, including those with secondary breast cancer. Health Education England is also working to expand the number of CNS and develop clear CNS competencies and routes into training.</p><p>The National Cancer Registration and Analysis Service (NCRAS) has mandated collection of breast cancer recurrence data in its Cancer Services and Outcomes Dataset (COSD) since 2013. Hospital trusts are also required to submit recurrence data in the Cancer Waiting Times (CWT) dataset. Data published on the NCRAS legacy website shows that of the 140 trusts that could be expected to be collecting data on breast cancer recurrence in 2016, 140 submitted data for 2016 diagnoses through the COSD or CWT data collection mechanisms. The NCRAS legacy website is available at the following link:</p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222763 question first answered 21/02/2019 14:58:17 answering member 4067 label Biography information for Steve Brine
tabling member	4212 label Biography information for Debbie Abrahams

1063828

registered interest
date	18/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the statement on page 72 of the Independent Cancer Taskforce's Cancer Strategy for 2015-2020 that all NHS trusts should now be recording recurrent and secondary breast cancer patients, how many and what proportion of NHS trusts are undertaking such recording.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	222763
answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The NHS Cancer Programme aims to improve access to cancer Clinical Nurse Specialists (CNS) for all cancer patients when they need it, including those with secondary breast cancer. Health Education England is also working to expand the number of CNS and develop clear CNS competencies and routes into training.</p><p>The National Cancer Registration and Analysis Service (NCRAS) has mandated collection of breast cancer recurrence data in its Cancer Services and Outcomes Dataset (COSD) since 2013. Hospital trusts are also required to submit recurrence data in the Cancer Waiting Times (CWT) dataset. Data published on the NCRAS legacy website shows that of the 140 trusts that could be expected to be collecting data on breast cancer recurrence in 2016, 140 submitted data for 2016 diagnoses through the COSD or CWT data collection mechanisms. The NCRAS legacy website is available at the following link:</p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222762 question first answered 21/02/2019 14:58:17 answering member 4067 label Biography information for Steve Brine
tabling member	4212 label Biography information for Debbie Abrahams